PetIQ, Inc. (PETQ)
| Market Cap | 919.17M |
| Revenue (ttm) | 1.13B +13.6% |
| Net Income | 13.19M |
| EPS | 0.45 |
| Shares Out | 29.67M |
| PE Ratio | 68.80 |
| Forward PE | 17.40 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | 30.98 |
| Day's Range | 30.98 - 30.98 |
| 52-Week Range | 15.09 - 31.06 |
| Beta | 1.74 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 5, 2024 |
About PETQ
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the... [Read more]
Financial Performance
Financial StatementsNews
PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group
EAGLE, Idaho and NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced the successfu...
PetIQ, Inc. Announces Results of Special Meeting of Stockholders
Reports Merger Agreement with Bansk Group Approved by Stockholders and Anticipates a Closing Date of October 25, 2024 Reports Merger Agreement with Bansk Group Approved by Stockholders and Anticipates...
PETIQ INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PetIQ, Inc. - PETQ
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of PetIQ, Inc. (Nas...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GTHX, PETQ on Behalf of Shareholders
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breac...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PETQ, DRQ on Behalf of Shareholders
NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breac...
PetIQ agrees to be acquired by Bansk Group in all-cash deal valued at $1.5 billion
PetIQ Inc. PETQ, -0.63%, an Idaho-based pet wellness company, said Wednesday it's agreed to be acquired by investment firm Bansk Group for $31 a share in cash, or about $1.5 billion. The price is equa...
Bansk Group to buy PetIQ for $1.5 billion
Private equity firm Bansk Group will acquire pet health company PetIQ for about $1.5 billion in cash, the companies said on Wednesday.
PetIQ, Inc. Reports Second Quarter 2024 Financial Results
Generates Record Second Quarter 2024 Net Sales and Net Income Record Adjusted EBITDA of $39.0 Million Exceeds Company's Second Quarter 2024 Guidance PetIQ and Bansk Group Sign Definitive Merger Agreem...
PetIQ, Inc. to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
EAGLE, Idaho, July 17, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced it will report financial r...
PetIQ, Inc. to Participate in the Oppenheimer 24th Annual Consumer Growth and E-Commerce Conference
EAGLE, Idaho, June 05, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and wellness company, today announced that members of its execu...
PetIQ, Inc. to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
EAGLE, Idaho, April 22, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced it will report financial ...
PetIQ, Inc. Celebrates Expansion of Minties® Dental Treats Brand With Launch of New Dental Chew for Large-Sized Dogs
Minties® Products Offer Pets Fresh Breath and Help Keep Teeth Clean and Healthy Minties® Products Offer Pets Fresh Breath and Help Keep Teeth Clean and Healthy
PetIQ, Inc. Kicks Off Flea & Tick Season With NextStar® Campaign Introducing New Pet Parent Education and Veterinary Support Resources
Vet-Recommended NextStar® “Kills, Protects, Prevents” Without a Prescription; Telehealth Support Line with Real-Time, Live Veterinary Professionals Available for Pet Parents Vet-Recommended NextStar® ...
PetIQ, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
Record Full Year 2023 Net Sales Increase 19.6% Year-Over-Year to Over $1.1 Billion Adjusted EBITDA Exceeds Company's Full Year 2023 Guidance Reports Highest Annual Cash from Operations in the Company'...
PetIQ, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024
EAGLE, Idaho, Feb. 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results f...
PetIQ, Inc.'s New SENTRY® Portable Calming Diffuser Helps Calm Dogs and Cats During the Busy Holiday Season and Beyond
Portable Calming Diffuser Uses Scientifically Proven Pheromone Technology To Help Pets Lead Happier, Less Stressful Lives Portable Calming Diffuser Uses Scientifically Proven Pheromone Technology To H...
PetIQ, Inc. to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023
EAGLE, Idaho, Oct. 17, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results f...
PetIQ, Inc. Reports Second Quarter 2023 Financial Results
Record Second Quarter 2023 Net Sales Increase 25% to $314.5 Million Net Sales and Adjusted EBITDA Exceeds Company's Second Quarter 2023 Guidance Record Second Quarter Cash from Operations of $57.7 M...
PetIQ, Inc. to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
EAGLE, Idaho, July 20, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results f...
PetIQ, Inc. to Participate in Two Upcoming June Investor Conferences
EAGLE, Idaho, June 01, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced members of the management team wil...
PetIQ, Inc. to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023
EAGLE, Idaho, April 18, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results ...
PetIQ, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company Guidance Updates Adjusted EBITDA Methodology Reports Record Annual Cash from Operations of $ 48.0 Million Completes Complementary, Mar...
PetIQ, Inc. to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023
EAGLE, Idaho, Jan. 31, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results f...
Simple Mills Appoints Sheryl O'Loughlin to Board of Directors
CHICAGO--(BUSINESS WIRE)--Simple Mills, the company on a mission to advance the holistic health of the planet and its people through delicious, better-for-you foods, today announced the addition of ...
PetIQ, Inc. Reports Third Quarter 2022 Financial Results
Third Quarter 2022 Net Sales of Approximately $210 Million at the High-End of Guidance Adjusted EBITDA Exceeds Company's Third Quarter Guidance Reports Record Quarterly Cash from Operations of $64.5...